Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of…
By R. Bone, R. Balk, F. Cerra, R. Dellinger, A. Fein, W. Knaus, R. Schein, W. Sibbald. 1992
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Mark P. Sendak
- Chong Jai Kim
- Kjell Johnson
- Joseph D. Futoma
- S. Hughes
- W. Schulte
- Roberto Romero
- P. Chaemsaithong
Citations in the corpus
- Supersparse linear integer models for optimized medical scoring systems (2015, methodology): “These models are used to assess the risk of numerous serious medical conditions since they allow physicians to make quick predictions, without extensive training, and without the use of a computer (see e.g., Knaus et al., 1991, Bone et al., 1992, Moreno et al., 2005).”
- Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. (2004, methodology): “We studied critically ill patients meeting criteria for sepsis syndrome (4) and having a sepsis score (61) of 3 or higher.”
- Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View (2013, background): “In contrast, the diagnosis of sepsis requires clinical evidence of infection along with an underlying SIRS disease state.”
- Applied Predictive Modeling (2013, background): “For example, Bone et al. (1992) define a set of clinical symptoms to diagnose Systemic Inflammatory Response Syndrome (SIRS).”